Effect of circulating exosomes in patients with sepsis on T cell function.
10.3760/cma.j.cn121430-20230228-00122
- Author:
Junhong HUANG
1
;
Guoge HUANG
2
;
Chunmei ZHANG
2
;
Mengling JIAN
2
;
Xin LI
2
;
Wenqiang JIANG
1
Author Information
1. School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, Guangdong, China.
2. Emergency Intensive Care Unit, Department of Emergency, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, Guangdong, China. Corresponding author: Jiang Wenqiang, Email: jiangwenqiang@gdph.org.cn.
- Publication Type:Journal Article
- MeSH:
Humans;
Leukocytes, Mononuclear;
Exosomes/metabolism*;
Programmed Cell Death 1 Receptor/metabolism*;
T-Lymphocytes, Regulatory/metabolism*;
Sepsis/metabolism*
- From:
Chinese Critical Care Medicine
2023;35(6):586-591
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of circulating exosomes (EXO) on T cell function in patients with sepsis.
METHODS:Plasma EXO were obtained by ultracentrifugation from 10 patients with sepsis admitted to the emergency intensive care unit of Guangdong Provincial People's Hospital Affiliated to Southern Medical University. Transmission electron microscopy observation, nanoparticle tracking analysis (NTA), and Western blotting were used to detect EXO markers to identify their characteristics. Furthermore, peripheral blood mononuclear cells (PBMC) were isolated from the peripheral blood of 5 healthy volunteers, primary T cells were sorted by magnetic beads and expanded in vitro. After 24 hours of intervention with different doses (0, 1, 2.5, 5, 10 mg/L) of circulating EXO in patients with sepsis, T-cell activity was assessed using a cell counting kit-8 (CCK-8). The expression of T cell activation indicators CD69 and CD25 were observed using flow cytometry. Additional evaluations were performed on immunosuppressive indicators including the expression of programmed cell death 1 (PD-1) in CD4+ T cells and the proportion of regulatory T cell (Treg).
RESULTS:The identification results confirmed that the successful isolation of EXO from the plasma of sepsis patients. The expression level of circulating EXO in sepsis patients was higher than that in healthy control group (mg/L: 48.78±5.14 vs. 22.18±2.25, P < 0.01). After 24 hours of intervention with 5 mg/L of plasma EXO from sepsis patients, T cells activity began to show suppression [(85.84±0.56)% vs. (100.00±0.00)%, P < 0.05]. As the dosage increased, after 24 hours of intervention with 10 mg/L of EXO, T cells activity was significantly suppressed [(72.44±2.36)% vs. (100.00±0.00)%, P < 0.01]. Compared with the healthy control group, after T cells intervention with plasma EXO from sepsis patients, the expression of early activation marker CD69 was significantly reduced [(52.87±1.29)% vs. (67.13±3.56)%, P < 0.05]. Meanwhile, there was an upregulation of PD-1 expression in T cells [(57.73±3.06)% vs. (32.07±0.22)%, P < 0.01] and an increase in the proportion of Treg [(54.67±1.19)% vs. (24.60±3.51)%, P < 0.01]. However, the expression of the late activation marker CD25 remained stable [(84.77±3.44)% vs. (85.93±2.32)%, P > 0.05].
CONCLUSIONS:Circulating EXO in sepsis patients induce T cell dysfunction, which may be a novel mechanism lead to immunosuppression in sepsis.
